sb 203580 has been researched along with ap23464 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ap23464) | Trials (ap23464) | Recent Studies (post-2010) (ap23464) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 9 | 0 | 2 |
| Protein | Taxonomy | sb 203580 (IC50) | ap23464 (IC50) |
|---|---|---|---|
| Chain A, Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.0004 | |
| Chain A, Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.0004 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.0005 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.0004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angiolini, M; Ardini, E; Casale, E; Zuccotto, F | 1 |
1 review(s) available for sb 203580 and ap23464
| Article | Year |
|---|---|
Through the "gatekeeper door": exploiting the active kinase conformation.
Topics: Drug Design; Humans; Protein Kinase Inhibitors; Protein Kinases; Substrate Specificity | 2010 |